Business and management
N10/3/BUSMT/SP1/ENG/TZ0/XX
88105013
BUSINESS AND MANAGEMENT
STANDARD LEVEL
PAPER 1
Thursday 18 November 2010 (afternoon)
1 hour 15 minutes
INSTRUCTIONS to candidates
not open this examination paper until instructed to do so.
Do
Read the case study carefully.
Section A: answer two questions.
Section B: answer the compulsory question.
8810-5013
3 pages
© International Baccalaureate Organization 2010
–2–
N10/3/BUSMT/SP1/ENG/TZ0/XX
SECTION A
Answer two questions from this section.
1.
N-Pharma is now a successful business, but it initially struggled: “poor cash flow meant that the early years were financially challenging” (lines 6–7).
Outline two problems that Yukio Nakamura’s business start-up may have faced.
[4 marks]
(b) Construct a fully labelled Ansoff matrix to show N-Pharma’s possible growth strategies.
[4 marks]
(c)
Analyse the value of “social and environmental audits” (line 107) to
N-Pharma.
[7 marks]
2.
(a)
Define the following terms:
(a)
(i)
span of control (line 60)
[2 marks]
(ii) empowerment (line 64).
[2 marks]
(b) Comment on the effectiveness of Susan James’ leadership style in the
Canadian subsidiary of N-Pharma.
[4 marks]
(c)
Analyse the appropriateness of a cost-based pricing strategy (line 29) for
N-Pharma’s drugs.
[7 marks]
3.
(a)
Tadashi Agi has been appointed to the new post of “director of corporate social responsibility” (line 101). Outline two methods of recruitment that could have been used in this appointment.
[4 marks]
(b) Explain how Tadashi Agi could use new technologies within N-Pharma to communicate his ethical vision effectively with stakeholders (lines 105–106).
[4 marks]
(c)
8810-5013
Tadashi Agi is now writing a “Charter of Ethics”, setting ethical objectives for
N-Pharma (lines 102–103). Examine the reasons why organizations
88105013
BUSINESS AND MANAGEMENT
STANDARD LEVEL
PAPER 1
Thursday 18 November 2010 (afternoon)
1 hour 15 minutes
INSTRUCTIONS to candidates
not open this examination paper until instructed to do so.
Do
Read the case study carefully.
Section A: answer two questions.
Section B: answer the compulsory question.
8810-5013
3 pages
© International Baccalaureate Organization 2010
–2–
N10/3/BUSMT/SP1/ENG/TZ0/XX
SECTION A
Answer two questions from this section.
1.
N-Pharma is now a successful business, but it initially struggled: “poor cash flow meant that the early years were financially challenging” (lines 6–7).
Outline two problems that Yukio Nakamura’s business start-up may have faced.
[4 marks]
(b) Construct a fully labelled Ansoff matrix to show N-Pharma’s possible growth strategies.
[4 marks]
(c)
Analyse the value of “social and environmental audits” (line 107) to
N-Pharma.
[7 marks]
2.
(a)
Define the following terms:
(a)
(i)
span of control (line 60)
[2 marks]
(ii) empowerment (line 64).
[2 marks]
(b) Comment on the effectiveness of Susan James’ leadership style in the
Canadian subsidiary of N-Pharma.
[4 marks]
(c)
Analyse the appropriateness of a cost-based pricing strategy (line 29) for
N-Pharma’s drugs.
[7 marks]
3.
(a)
Tadashi Agi has been appointed to the new post of “director of corporate social responsibility” (line 101). Outline two methods of recruitment that could have been used in this appointment.
[4 marks]
(b) Explain how Tadashi Agi could use new technologies within N-Pharma to communicate his ethical vision effectively with stakeholders (lines 105–106).
[4 marks]
(c)
8810-5013
Tadashi Agi is now writing a “Charter of Ethics”, setting ethical objectives for
N-Pharma (lines 102–103). Examine the reasons why organizations